Next Article in Journal
Integrative Approaches in Structural Biology: A More Complete Picture from the Combination of Individual Techniques
Next Article in Special Issue
Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
Previous Article in Journal
Ziziphora taurica subsp. taurica: Analytical Characterization and Biological Activities
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 9
Issue 8
10.3390/biom9080368
Review Report
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D2 Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor

Biomolecules 2019, 9(8), 368; https://doi.org/10.3390/biom9080368
by Lakshmi Vasudevan 1,2, Dasiel O. Borroto-Escuela 3, Jelle Huysentruyt 1, Kjell Fuxe 3, Deepak K. Saini 2,* and Christophe Stove 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomolecules 2019, 9(8), 368; https://doi.org/10.3390/biom9080368
Submission received: 12 July 2019 / Revised: 12 August 2019 / Accepted: 13 August 2019 / Published: 14 August 2019
(This article belongs to the Special Issue Dopamine Receptor in Health and Diseases)

Round 1

Reviewer 1 Report

This manuscript uses a variety of tools to test whether or not dopamine D2 and Mu opioid receptors interact forming heterodimers, and how this protein-protein interaction changes the traffic of Mu receptors from the membrane to intracellular compartments. The manuscript is very well written and clear. The authors have extensive experience in the technologies used and presented in this manuscript. The conclusion is well supported with the data presented.

One minor comment, I think the discussion could be improved. Significant length of the discussion is focused in supporting evidences about the existence of heterodimers or oligomeric receptors complexes, very little discussion is found regarding the functional significance D2-Mu receptors hererodimers. The dopamine-opioid interplay in physiological events, this is particularly interesting given that D2 receptors inhibits the internalization of Mu receptors. There are pharmacological evidences of synergistic antinociceptive effect between D2 and Mu agonists [Mercado-Reyes et al., 2019], changes in morphine tolerance by the blockade of D2 dopamine receptors, have been also described [Dai et al., 2016]. How the results presented in this manuscript are in agreement or not, with the physiological and pharmacological evidences is missing in the discussion.

Another minor comment, is not clear the explanation in line 408 page 11 of why when using NanoBiT the signal obtained for the tag D2LR-SmBiT+MOR-LgBiT was higher than the switched tag (MOR-SmBiT+D2LR-LgBiT), please elaborate why you mean by "specific conformation".

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The manuscript is interesting.

I have only minor comments.

 

 

1.The manuscript would benefit from inclusion of introducing/bridging sentences between the individual parts of the "Results" that explain the logical order and rationale for the experiments

2. Please add the IC50.

 

In the conclusions , the Authors should highlight the possible clinical significance of their findings

 


Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop